Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RANOLAZINE for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 25 adverse event reports in the FDA FAERS database where RANOLAZINE was used for Atrial fibrillation.

Most Reported Side Effects for RANOLAZINE

Side Effect Reports % Deaths Hosp.
Death 692 7.3% 687 45
Myocardial infarction 610 6.4% 40 352
Stent placement 593 6.2% 1 325
Chest pain 592 6.2% 8 361
Angina pectoris 583 6.1% 3 163
Dizziness 517 5.4% 14 141
Dyspnoea 348 3.7% 12 172
Cerebrovascular accident 334 3.5% 15 162
Fall 299 3.1% 20 197
Off label use 270 2.8% 9 67
Nausea 266 2.8% 5 63
Cardiac disorder 261 2.7% 20 144
Intentional product use issue 261 2.7% 0 105
Diabetes mellitus 257 2.7% 4 41
Malaise 240 2.5% 5 105

Other Indications for RANOLAZINE

Angina pectoris (6,036) Product used for unknown indication (2,643) Coronary artery disease (128) Chest pain (80) Myocardial ischaemia (61) Ventricular arrhythmia (54) Angina unstable (44) Cardiac disorder (44) Prinzmetal angina (27) Dyspnoea (24)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

RANOLAZINE Full Profile All Atrial fibrillation Drugs RANOLAZINE Demographics RANOLAZINE Timeline